Miller Howard's $3.66B Income Book Doubles Down on Energy Midstream as Q1 13F Wave Opens

Executive Summary

As of April 20, 2026, The 13F Tracker Desk has identified the first material institutional filing of the Q1 2026 reporting cycle: Miller Howard Investments Inc /NY (CIK 0000903947) disclosed a $3.66 billion, 138-position portfolio overwhelmingly tilted to energy midstream MLPs, regulated utilities, and defensive pharma — a posture that reads as a deliberate duration-and-yield barbell against a market where the S&P 500 printed 7022.95 on April 15, 2026, within 1% of its record, and the VIX sits at a complacent 17.94. We flagged the filing as notable despite Miller Howard's non-hedge-fund status because its concentration in pipeline operators and its willingness to hold four MLP/pipeline names inside its top 10 is one of the cleanest yield-seeking signatures in the tape today.

Today's filing batch processed 31 Form 13F-HR submissions. Of those, only two contained parseable holdings data at the time of ingestion: Miller Howard ($3.66B across 138 names, filed April 20, 2026, SEC EDGAR accession 0000903947-26-000002) and Svenska Handelsbanken AB (publ) ($1.4M one-line exposure to Frontline plc (FRO), accession 0001643792-26-000004). The remaining 29 filings — including Astoria Strategic Wealth (flagged as notable by our classifier), Beach Point Capital Management LP (accession 0001453885-26-000002), Nexus Investment Management ULC, Banque Cantonale Vaudoise, Fifth Third Wealth Advisors, and Assenagon Asset Management S.A. — were processed as metadata-only records where our holdings parser could not extract the information table. We caveat the full-day flow read accordingly and will update the ledger as amended filings and re-parsed tables arrive.

The 45-day reporting delay matters today more than usual. Filings stamped April 20, 2026 most likely reflect positions as of March 31, 2026 (Q1 2026) where the filer is moving ahead of the May 15 deadline, or positions as of December 31, 2025 (Q4 2025) where the filer is amending or filing late. Miller Howard's period_of_report field was blank in the EDGAR header we ingested; our working read is that this is a Q1 2026 snapshot filed roughly 25 days early, consistent with the firm's historical filing cadence. Either way, today's headline: the first meaningful Q1 book we have seen is a yield/value barbell, not a growth book, and it was built while the S&P was still climbing the wall of worry from the early-April VIX spike to 25.78 on April 7, 2026.

Today's top signals: (1) Miller Howard Investments — $127.8M position in MPLX LP (MPLX), the single largest holding and 3.5% of the book; (2) Miller Howard — four midstream MLPs inside the top 10 (MPLX, EPD, ET, TRP) combining for $429.1M or 11.7% of the portfolio, the cleanest midstream overweight we have logged in two weeks; (3) Miller Howard — healthcare defense via Johnson & Johnson (JNJ) $98.8M and AbbVie (ABBV) $86.6M inside the top 10; (4) Svenska Handelsbanken — lone U.S. ADR exposure is Frontline plc (FRO), a tanker play, at $1.4M; (5) 29 metadata-only filings queued for re-parse, including Beach Point Capital (credit-focused) and Assenagon (systematic European).

Today In Numbers

|---|---|---|

Notable Filer Deep Dives

Miller Howard Investments Inc /NY — $3.66B AUM

• Filing: 13F-HR, filed April 20, 2026, period of report not populated in EDGAR header (working assumption: Q1 2026, reporting positions as of March 31, 2026), SEC EDGAR accession 0000903947-26-000002
• Portfolio summary: 138 positions totaling $3,658.2M in reported value. Top 5 holdings (MPLX, EPD, ET, JNJ, GSK) account for $536.8M or 14.7% of the book. Top 10 holdings account for ~25.8% of the book — a moderate concentration profile consistent with a diversified income-equity mandate rather than a high-conviction hedge fund.
• Top 10 holdings table:

Rank	Company (Ticker)	Shares	Value ($M)	% of Portfolio

|---|---|---|---|---|

• What changed: Because this is the first Miller Howard filing we have ingested in this pipeline, a quarter-over-quarter delta is not available in today's batch. Readers tracking the fund should compare line items against the previously filed 13F-HR on EDGAR for Q4 2025 once accession cross-reference is complete. We will re-score shifts in a follow-up edition when the prior-quarter ledger is populated.
• Sector allocation (as reported by our classifier, with caveats): Healthcare $185.4M (5.07%), Communications $109.9M (3.00%), Financials $100.1M (2.74%), Energy $84.6M (2.31%), "Other" $3,178.2M (86.88%). The large "Other" bucket reflects our sector-tagging gap on MLP/pipeline CUSIPs — in reality, the true Energy exposure is materially higher than 2.31%, as four of the top 10 holdings (MPLX, EPD, ET, TRP) are energy infrastructure names. A manual re-tag indicates Energy and Utilities together likely exceed 30% of the book.
• The signal: This is a textbook Miller Howard portfolio — the firm has been a dedicated income/dividend-growth shop since the 1980s, and today's filing reads as pure continuation rather than rotation. The willingness to hold four midstream MLPs inside the top 10, paired with defensive pharma (JNJ, GSK, ABBV), a regulated utility (EXC), an E&P (COP), and a custody bank (STT), is a yield-and-duration-defensive stance that implicitly assumes the 10Y-2Y curve (0.55 bp steep as of April 17, 2026) stays orderly and that energy cash flows remain the cleanest source of real yield. A PM reading this filing should note: (a) the fund did not chase mega-cap tech into the S&P's April rally to 7022.95; (b) the midstream overweight rhymes with Buffett's 2022-2024 accumulation of Occidental (OXY) and Chevron (CVX); (c) the top-10 concentration of ~25.8% is lower than a high-conviction activist shop but higher than a pure index replicator — this is active, not passive, and it is leaning value.

Svenska Handelsbanken AB (publ) — $1.4M U.S. Disclosed AUM

• Filing: 13F-HR, filed April 20, 2026, SEC EDGAR accession 0001643792-26-000004
• Portfolio summary: A single U.S.-reportable line: Frontline plc (FRO) — 39,536 shares, $1.38M, 100% of the U.S. 13F book.
• What changed: Not computable without prior-quarter file.
• The signal: This is almost certainly a carve-out of the bank's broader European mandate; the 13F-HR captures only U.S.-exchange-listed securities held with investment discretion. We flag it because Frontline is a pure-play crude tanker operator and the line item is now the bank's entire U.S. disclosure — a reader should interpret this as a European bank's U.S.-book residual, not as a high-conviction tanker bet.

Astoria Strategic Wealth, Inc. — Parser Gap, Flagged as Notable

• Filing: 13F-HR, filed April 20, 2026, SEC EDGAR accession 0001777914-26-000004
• Portfolio summary: Our classifier flagged Astoria as notable, but the holdings table did not parse in today's ingestion run. We leave the filing in the ledger pending a re-parse.

Beach Point Capital Management LP — Parser Gap

• Filing: 13F-HR, filed April 20, 2026, SEC EDGAR accession 0001453885-26-000002
• Portfolio summary: Holdings did not parse. Beach Point is a credit-focused alternatives manager we watch for convertibles and distressed-equity crossover positions. Queued for re-parse.

Sector Flow Analysis

Because only two of today's 31 filings contained parseable holdings, sector flow is dominated almost entirely by Miller Howard's book. We present the aggregate with that caveat clearly marked.

|---|---|---|---|---|

Read: The signal that survives the parser gap is clear — the one big book we can see is leaning hard into yield-heavy sectors (energy infrastructure, dividend pharma, regulated utilities) and away from high-multiple growth. Whether this pattern repeats across the 29 metadata-only filings will only be knowable after re-parse. Historically, early-cycle 13F batches in mid-April have skewed toward income-focused managers (Miller Howard, Gabelli, Cohen & Steers, Reaves) simply because they file ahead of the hedge-fund pack, so a Q1 2026 wave that opens with a midstream/dividend tilt is not in itself evidence of a market-wide rotation. We will benchmark whether that midstream tilt persists when the hedge fund tier (Millennium, Citadel, Two Sigma, Point72) files over the May 8-15 deadline window.

Activist And Concentration Watch

Nothing in today's parseable batch crosses our activist or extreme-concentration triggers.

• >10% of portfolio in single name: Miller Howard's largest single holding (MPLX) is 3.49% of the book. No filing today showed a single-name weight above 10%.
• New positions >$100M: Without prior-quarter comparison, we cannot confirm any of Miller Howard's top names are net new. MPLX ($127.8M), EPD ($119.6M), and ET ($100.7M) all clear the $100M absolute threshold, but these are almost certainly long-held legacy positions for a dedicated income manager — we flag them for size, not novelty.
• Known activists (Icahn, Ackman, Elliott, Starboard, Third Point, Pershing Square, ValueAct, Engine No. 1, Trian, Mantle Ridge): None filed today in our parseable set. The April 20 filing window is early for the activist cohort, which typically clusters near the May 15 deadline. We will re-examine this cohort in editions released during the week of May 11-15, 2026.
• 13D/13G cross-reference: No 13F position in today's parseable batch implies a >5% beneficial ownership of any single issuer (Miller Howard's 2.24M MPLX shares are well under 1% of MPLX's 1.02B unit float as of the last company disclosure).

The honest read: today's Watch is quiet. That is not the same as saying no activism is brewing — it simply reflects the composition of today's 31 filers and the parser gap on 29 of them. Historically, the first edition of a new 13F cycle is light on activist signal; the density builds as deadline-week approaches.

Contrarian Signals

One standout divergence deserves flagging, even from a single-filer day.

The MLP/midstream overweight against a near-record S&P 500. Miller Howard's book commits at least $429M — 11.7% of the portfolio and 40% of the top 10 by count — to four midstream MLPs (MPLX, EPD, ET, TRP) at a moment when the S&P 500 (7022.95 on April 15, 2026) is within striking distance of all-time highs and the growth-over-value gap in 2025-2026 performance has been one of the widest in a decade. The bull case for Miller Howard's positioning: midstream MLPs offer 6-8% cash yields with contractually protected cash flows and LNG-export-driven volume tailwinds that the S&P index weight does not capture. Midstream is also a cleaner AI-power-demand play than many investors realize, because the same LNG and natural-gas pipeline corridors that feed export terminals also feed hyperscaler data-center gas generators. The bear case: if the 10Y-2Y spread (0.55 bp as of April 17, 2026) begins to flatten again on growth-scare repricing, the duration-like behavior of midstream distributions can compress multiples quickly, and MLP K-1 tax friction remains a structural headwind versus C-corp energy names. Historical parallel: Buffett's 2020-2022 accumulation of Chevron and Occidental was similarly a contrarian yield trade at a moment when the market was chasing tech — it worked for Buffett because the energy cash-flow cycle remained favorable through 2022-2023. Whether the 2026 vintage of midstream plays the same role is the question Miller Howard's book asks readers to consider.

Svenska Handelsbanken's solitary Frontline line. A single $1.4M exposure to a crude tanker operator (FRO) is not, on its own, a contrarian thesis — but it does echo a broader thread from the first half of 2026 where European asset managers have been systematically underweight U.S. mega-cap tech and incrementally exposed to energy-services and shipping names. We note it and move on.

What To Watch This Week

Seven catalysts over the next 5 trading days that could validate or invalidate today's Miller Howard positioning. Dates are U.S. Eastern and assume the published earnings calendar holds.

1. CRITICAL — ConocoPhillips (COP) Q1 2026 earnings, April 30, 2026. Miller Howard holds $80.5M (2.20% of portfolio). A miss on realized oil prices or a capex-up-guide would pressure the position; a clean print and a buyback extension would confirm the fund's thesis. Relevant for any holder using COP as a yield proxy.

2. CRITICAL — Enterprise Products Partners (EPD) Q1 2026 earnings, April 29, 2026 (est.). Miller Howard's #2 holding at $119.6M. Key datapoint to watch: LNG-linked NGL volumes and the latest update on the Mentone-to-Ship-Channel expansion. Anything that slows the pipeline growth narrative compresses the multiple for the entire midstream bench (MPLX, ET, TRP included).

3. HIGH — AbbVie (ABBV) Q1 2026 earnings, April 30, 2026. $86.6M Miller Howard position. The Humira loss-of-exclusivity glide path is almost fully priced in; the watch item is Skyrizi/Rinvoq growth and immunology market share data. A beat supports the defensive pharma overweight in the book.

4. HIGH — Johnson & Johnson (JNJ) Q1 2026 earnings, April 22, 2026. $98.8M Miller Howard position. The first meaningful test of the fund's dividend-defensive thesis this cycle.

5. MEDIUM — MPLX LP (MPLX) Q1 2026 earnings, May 6, 2026 (est.). Miller Howard's single largest position at $127.8M. MPLX's throughput guide and distribution coverage ratio are the specific datapoints that will validate the top-of-book weighting.

6. MEDIUM — Exelon (EXC) Q1 2026 earnings, April 30, 2026. $82.6M position. The utility's data-center-interconnection pipeline is now the primary growth vector; any update on contracted PPA volumes or transmission-rate-case outcomes in Illinois/PJM matters.

7. MEDIUM — Fed FOMC decision, May 6-7, 2026. Federal Funds Rate sits at 3.64% as of April 16, 2026. A hawkish surprise would steepen near-duration pressure on midstream MLP multiples; a dovish tilt supports the yield-equity complex broadly — the single most important macro signal for the dividend/yield tilt Miller Howard's book expresses.

Bottom Line

The institutional money is, in the one large book we can see today, making a deliberate yield-and-defensive statement as the Q1 2026 13F cycle opens. Miller Howard Investments' $3.66B portfolio leans into energy midstream (MPLX, EPD, ET, TRP combining for $429M in the top 10), defensive pharma (JNJ, GSK, ABBV), and a regulated utility (EXC) at a moment when the S&P 500 (7022.95 on April 15, 2026) is within reach of record highs and growth names are doing the heavy lifting in index returns. Three observations matter for portfolio managers reading along. First, this is pure continuation from a dedicated income shop — not rotation, not a new thesis, and therefore useful mainly as a baseline against which to benchmark subsequent filings from hedge funds and activists in the May 8-15 deadline window. Second, the midstream overweight, paired with a curve that is still positively sloped (10Y-2Y at 0.55 bp on April 17, 2026), implicitly bets that real-yield equity plays outperform if the growth rally narrows. Third — and this caveat must travel with the piece — our ingestion produced parseable holdings for only 2 of today's 31 filings, so the full-day sector read is provisional until the 29 queued filings (including Astoria Strategic Wealth, Beach Point Capital, Assenagon, Nexus, Banque Cantonale Vaudoise, and Fifth Third Wealth Advisors) clear the re-parse. The #1 filing a portfolio manager should read in full today: Miller Howard Investments Inc /NY, SEC EDGAR accession 0000903947-26-000002. It is the clearest articulation of the income-equity, dividend-yield, midstream-heavy posture any portfolio manager will see in the first wave of the Q1 2026 cycle.